CIK: 0001512848 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 14, 2025
Total Value ($000): $1,822,265 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RYTM | RHYTHM PHARMACEUTICALS INC | 2,909,956 | $293,876 | 16.1% | $26.40 | +251.6% | COM | 76243J105 |
| ACLX | ARCELLX INC | 3,045,262 | $250,016 | 13.7% | $16.54 | +335.2% | COMMON STOCK | 03940C100 |
| — | VERONA PHARMA PLC | 2,252,994 | $240,417 | 13.2% | $8.67 | — | SPONSERED ADS | 925050106 |
| COUR | COURSERA INC | 12,867,769 | $150,682 | 8.3% | $45.00 | -75.9% | COM | 22266M104 |
| TRVI | TREVI THERAPEUTICS INC | 13,222,228 | $120,983 | 6.6% | $2.98 | +151.2% | COM | 89532M101 |
| CELC | CELCUITY INC | 2,144,261 | $105,926 | 5.8% | $10.53 | +280.0% | COM | 15102K100 |
| SVRA | SAVARA INC | 24,471,264 | $87,362 | 4.8% | $1.74 | +70.3% | COM | 805111101 |
| CRSP | CRISPR THERAPEUTICS AG | 1,058,570 | $68,606 | 3.8% | $20.40 | +181.5% | NAMEN AKT | H17182108 |
| MBX | MBX BIOSCIENCES INC | 3,614,486 | $63,254 | 3.5% | $22.87 | -41.5% | COM | 55287L101 |
| ZBIO | ZENAS BIOPHARMA INC | 2,733,719 | $60,689 | 3.3% | $17.62 | -7.6% | COM | 98937L105 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 7,692,298 | $57,000 | 3.1% | $20.37 | -74.0% | COM | 61225M102 |
| KRRO | KORRO BIO INC | 1,090,793 | $52,238 | 2.9% | $33.32 | -33.4% | COM | 500946108 |
| ORIC | ORIC PHARMACEUTICALS INC | 4,118,621 | $49,423 | 2.7% | $8.94 | +17.6% | COM | 68622P109 |
| GOSS | GOSSAMER BIO INC | 18,093,034 | $47,585 | 2.6% | $3.27 | -32.7% | COM | 38341P102 |
| AUPH | AURINIA PHARMACEUTICALS INC | 3,969,834 | $43,867 | 2.4% | $6.46 | +69.1% | COM | 05156V102 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 1,960,169 | $23,071 | 1.3% | $10.51 | -1.8% | COM | 71722W107 |
| — | NEUEHEALTH INC | 2,726,917 | $18,189 | 1.0% | $12.22 | — | COM NEW | 10920V404 |
| BDTX | BLACK DIAMOND THERAPEUTICS I | 4,448,757 | $16,861 | 0.9% | $23.88 | -87.8% | COM | 09203E105 |
| CVRX | CVRX INC | 2,026,083 | $16,350 | 0.9% | $28.00 | -73.1% | COM | 126638105 |
| CSBR | CHAMPIONS ONCOLOGY INC | 1,713,720 | $11,096 | 0.6% | $6.16 | +14.3% | COM NEW | 15870P307 |
| IVA | INVENTIVA SA | 1,462,586 | $8,323 | 0.5% | $7.21 | — | ADS | 46124U107 |
| OMDA | OMADA HEALTH INC | 364,115 | $8,051 | 0.4% | $17.31 | +18.3% | COM | 68170A108 |
| — | X4 PHARMACEUTICALS INC | 2,233,743 | $7,639 | 0.4% | $2.99 | — | COM | 98420X103 |
| NKTX | NKARTA INC | 3,568,781 | $7,387 | 0.4% | $26.42 | -92.2% | COM | 65487U108 |
| SNTI | SENTI BIOSCIENCES INC | 3,775,615 | $5,324 | 0.3% | $3.75 | -55.4% | COM NEW | 81726A209 |
| SYBX | SYNLOGIC INC | 2,922,772 | $4,875 | 0.3% | $2.94 | -49.3% | COM NEW | 87166L209 |
| MRKR | MARKER THERAPEUTICS INC | 1,625,678 | $1,451 | 0.1% | $2.77 | -55.5% | COM NEW | 57055L206 |
| OKUR | ONKURE THERAPEUTICS INC | 478,548 | $1,316 | 0.1% | $15.14 | -83.6% | COM CL A | 68277Q105 |
| IMA | IMAGENEBIO INC | 50,005 | $408 | 0.0% | $13.25 | 0.0% | COM | 45175G207 |